Damaris Pederson

Johnson & Johnson (United States)

Papers

2

Total Citations

31

H-Index

2

About

Dr. Damaris Pederson is a leading interventional pulmonologist whose work is transforming the landscape of minimally invasive lung cancer diagnostics. Her primary research focus is the clinical application and validation of robotic-assisted bronchoscopy for the diagnosis of peripheral pulmonary lesions. Dr. Pederson’s most significant contribution is her leadership of the landmark TARGET trial, a prospective, multicenter study that provides the highest level of evidence for the safety and diagnostic yield of robotic bronchoscopy. This work, published in 2025 and already garnering 27 citations, has established a new benchmark for procedural outcomes in the field. By systematically demonstrating the technology’s effectiveness across multiple institutions, she has provided the data necessary for its widespread clinical adoption, directly impacting the care pathway for patients with suspicious lung nodules. Her rigorous, evidence-based approach is helping to define best practices and set standards for the next generation of interventional pulmonology, making her a pivotal figure in the fight against lung cancer.

Research Focus

Key Achievements

2
H-Index
2
Papers
31
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
A Prospective, Multicenter Evaluation of Safety and Diagnostic Outcomes With Robotic-Assisted Bronchoscopy
27 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Johnson & Johnson (United States)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago